Baraclude vs Tyzeka >> <a href='read_msg.asp?message_id=14387802'>#msg-14387802</a> >> this post worth another look... also note the head to head study (Baraclude vs Tyzeka) is in progress First-line setting Tyzeka vs Baraclude 12-week PK study in Korea (40 patients, recruiting): <A HREF="http://www.clinicaltrials.gov/ct/show/NCT00412529" target="_blank">http://www.clinicaltrials.gov/ct/show/NCT00412529</A> Open-label extension of above trial out to 2 years (recruiting): <A HREF="http://www.clinicaltrials.gov/ct/show/NCT00467545" target="_blank">http://www.clinicaltrials.gov/ct/show/NCT00467545</A>